Flipping the switch on scleroderma

Scleroderma is a rare and often fatal disease, causing the thickening of tissue, that currently lacks a cure and any effective treatments. A group of researchers is looking to change that. The group has identified the core signaling pathway that activates the disease and the chemical compounds that can turn it off.